Synthetic nano-scale fibrous extracellular matrix

Journal of Biomedical Materials Research

Volumn 46, Issue 1, 1999, Pages 60-72

  Ma, Peter X ^a   Zhang, Ruiyun ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Fiber; Matrix; Morphology; Polymer; Scaffold; Tissue engineering

Indexed keywords

ANNEALING; BIODEGRADATION; COMPOSITION EFFECTS; DRYING; ELASTIC MODULI; GELATION; MORPHOLOGY; POLYESTERS; POROSITY; TENSILE STRENGTH; THERMAL EFFECTS; TISSUE CULTURE;

NANO-FIBROUS EXTRACELLULAR MATRIX;

BIOMATERIALS;

BIOMATERIAL; POLYMER;

ARTICLE; BIODEGRADATION; BIOENGINEERING; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; EXTRACELLULAR MATRIX;

ALGORITHMS; BIOCOMPATIBLE MATERIALS; EXTRACELLULAR MATRIX; GELS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MODELS, THEORETICAL; POLYGLYCOLIC ACID; POLYMERS; TEMPERATURE; TENSILE STRENGTH;

EID: 0032949079     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H     Document Type: Article

References (47)

1. Langer R, Vacanti J. Tissue engineering. Science 1993;260:920-926.
2. Nerem RM, Sambanis A. Tissue engineering: From biology to biological substitutes. Tissue Eng 1995;1:3-13.
3. Yannas IV. Tissue regeneration by use of collagen-glycosaminoglycan copolymers. Clin Mater 1992;9:179.
4. Natsume T, Ike O, Okada T, Takimoto N, Shimizu Y, Ikada Y. Porous collagen sponge for esophageal replacement. J Biomed Mater Res 1993;27:867-875.
5. Bell E, Rosenberg M, Kemp P, Gay R, Green G, Muthukumaran N, Nolte C. Recipes for reconstituting skin. J Biomech Eng 1991;113:113-119.
6. Ma PX, Langer R. Degradation, structure and properties of fibrous nonwoven poly(glycolic acid) scaffolds for tissue engineering, In: Mikos AG, et al., editors. Polymers in medicine and pharmacy. MRS, Pittsburgh: 1995. p 99-104.
7. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R, Winslow DN, Vacanti JP. Preparation and characterization of poly(l-lactic acid) foams. Polymer 1994;5:1068-1077.
8. Vacanti C, Vacanti J. Bone and cartilage reconstruction with tissue engineering approaches. Otolaryngol Clin North Am 1994;27:263-276.
9. Ma PX, Schloo BS, Mooney D, Langer R. Development of biomechanical properties and morphogenesis of in vitro tissue engineered cartilage. J Biomed Mater Res 1995;29:1587-1595.
10. Ma PX, Langer R. Fabrication of biodegradable polymer foams for cell transplantation and tissue engineering. In: Yarmush M, Morgan J, editors. Tissue engineering methods and protocols. Totowa, NJ: Humana Press, 1998. p 47-56.
11. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valves: Autologous valve leaflet replacement study in a lamb model. Circulation 1996;94(Suppl):II-164-II-168.
12. Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol 1972;54:626-637.
13. Strom SC, Michalopoulos G. Collagen as a substrate for cell growth and differentiation. Methods Enzymol 1982;82:544-555.
14. Grinnell F, Bennett MH. Ultrastructural studies of cell-collagen interactions. Methods Enzymol 1982;82:535-544.
15. Hay ED. Cell biology of extracellular matrix. 2nd edition, New York: Plenum Press; 1991.
16. Cima L, Vacanti J, Vacanti C, Ingber D, Mooney D, Langer R. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng 1991;113:143-151.
17. Matlaga B, Salthouse T. Ultrastructural observations of cells at the interface of a biodegradable polymer: Polyglactin 910. J Biomed Mater Res 1983;17:185-197.
18. Craig P, Williams J, Davis K, Magoun A, Levy A, Bogdansky S, Jones JJ. A biologic comparison of polyglactin 910 and polyglycolic acid synthetic absorbable sutures. Surg Gynecol Obstet 1975;141:1-10.
19. Cusick RA, Lee H, Sano K, Pollok JM, Utsunomiya H, Ma PX, Langer R, Vacanti JP. The effect of donor and recipient age on engraftment of tissue-engineered liver. J Pediatr Surg 1997;32: 357-360.
20. Kim TH, Lee HM, Utsonomiya H, Ma P, Langer R, Schmidt EV, Vacanti JP. Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering. Transplant Proc 1997;29:858-860.
21. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
22. Ma PX, Shin'oka T, Zhou T, Shum-Tim D, Lien J, Vacanti JP, Mayer J, Langer R. Biodegradable woven/nonwoven composite scaffolds for pulmonary artery engineering in an juvenile lamb model. Trans Soc Biomater 1997;20:295.
23. Vacanti C, Langer R, Schloo B, Vacanti J. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 1991;88:753-759.
24. Cao Y, Vacanti J, Ma X, Paige K, Upton J, Chowanski Z, Schloo B, Langer R, Vacanti C. Generation of neo-tendon using synthetic polymers seeded with tenocytes. Transplant Proc 1994; 26:3390-3392.
25. Cao Y, Vacanti JP, Ma PX, Paige KT, Upton J, Chowanski Z, Schloo B, Langer R, Vacanti CA. Tissue engineering of neotendon from poly(glycolic acid) scaffolds and tenocytes. In: Mikos AG, Leong KW, Yaszemski MJ, Tamada JA, Radomsky ML, editors. Polymers in medicine and pharmacy. Pittsburgh: MRS, 1995. p 83-89.
26. Vacanti C, Kim W, Upton J, Vacanti M, Mooney D, Schloo B, Vacanti J. Tissue-engineered growth of bone and cartilage. Transplant Proc 1993;25:1019-1021.
27. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valve leaflets: Does cell origin affect outcome? Circulation 1997;96(Suppl):II-102-II-107.
28. Zund G, Breuer CK, Shinoka T, Ma PX, Langer R, Mayer JE, Vacanti JP. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 1997;11:493-497.
29. Breuer CK, Shin'oka T, Tanel RE, Zund G, Mooney DJ, Ma PX, Miura T, Colan S, Langer R, Mayer JE, Vacanti JP. Tissue engineering lamb heart valve leaflets. Biotechnol Bioeng 1996;50: 562-567.
30. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60(Suppl):5513-5516.
31. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE Jr. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-545.
32. Jamshidi K, Hyon SH, Ikada Y. Thermal characterization of polylactides. Polymer 1988;29:2229-2234.
33. Fischer EW, Sterzel HJ, Wegner G. Investigation of the structure of solution grown crystals of lactide copolymers by means of chemical reactions. Kolloid-Zeitschrift Zeitschrift Polymere 1973;251:980-990.
34. Coombes AG, Heckman JD. Gel casting of resorbable polymers: 2. In-vitro degradation of bone graft substitutes. Biomaterials 1992;13:297-307.
35. Agrawal CM, Best J, Heckman JD, Boyan BD. Protein release kinetics of a biodegradable implant for fracture non-unions. Biomaterials 1995;16:1255-1260.
36. Hubbell JA, Massia SP, Drumheller PD. Surface-grafted cell-binding peptides in tissue engineering of the vascular graft. Ann NY Acad Sci 1992;665:253-258.
37. Lin HB, Sun W, Mosher DF, Garcia-Echeverria C, Schaufelberger K, Lelkes PI, Cooper SL. Synthesis, surface, and cell-adhesion properties of polyurethanes containing covalently grafted RGD-peptides. J Biomed Mater Res 1994;28:329-342.
38. Dee KC, Rueger DC, Andersen TT, Bizios R. Conditions which promote mineralization at the bone-implant interface: A model in vitro study. Biomaterials 1996;17:209-215.
39. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J Biomed Mater Res 1997;37:9-19.
40. Zhang R, Ma PX. Poly(alpha-hydroxy acids)/hydroxyapatite porous composites for bone tissue engineeering: 1. Preparation and morphology. J Biomed Mater Res 1999;44:446-455.
41. Zhang R, Ma PX. Porous poly(L-lactic acid)/apatite composites created by a biomimetic process. J Biomed Mater Res 1999; 45:285-293.
42. Hollinger JO, Schmitz JP. Macrophysiologic roles of a delivery system for vulnerary factors needed for bone regeneration. Ann NY Acad Sci 1997;831:427-437.
43. Hollinger JO, Leong K. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins. Biomaterials 1996;17:187-194.
44. Schugens C, Grandfils C, Jerome R, Teyssie P, Delree P, Martin D, Malgrange B, Moonen G. Preparation of a macroporous biodegradable polylactide implant for neuronal transplantation. J Biomed Mater Res 1995;29:1349-1362.
45. Hsu YY, Gresser JD, Stewart RR, Trantolo DJ, Lyons CM, Simons GA, Gangadharam PR, Wise DL. Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods. J Pharmaceut Sci 1996;85:706-713.
46. Lo H, Kadiyala S, Guggino SE, Leong KW. Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J Biomed Mater Res 1996;30:475-484.
47. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996;17:93-102.